Stockreport

Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF BOSTON, April 01, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal fo [Read more]